Compass Therapeutics (CMPX) Non-cash Items (2020 - 2026)

Compass Therapeutics' Non-cash Items history runs 7 years deep, the most recent figure standing at $32.5 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 51.04% year-over-year to $32.5 million; the TTM figure through Mar 2026 stood at $32.5 million (up 51.04% YoY), while the FY2025 annual figure was $36.6 million, up 6223.66% from the prior year.
• Non-cash Items came in at $32.5 million for Q1 2026 at Compass Therapeutics, down from $36.6 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $36.6 million in Q4 2025 to a low of $11000.0 in Q4 2023.
• A 5-year average of $11.4 million and a median of $9.8 million in 2022 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items sank 99.83% in 2023 and jumped 6223.66% in 2025, its largest moves.
• Compass Therapeutics' Non-cash Items stood at $6.3 million in 2022, then tumbled by 99.83% to $11000.0 in 2023, then soared by 5163.64% to $579000.0 in 2024, then surged by 6223.66% to $36.6 million in 2025, then decreased by 11.31% to $32.5 million in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $32.5 million, $36.6 million, and $11.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison